Albert Sokol - McDermott Will & Emery


Albert (Al) L. Sokol has 40 years of experience representing a variety of large, medium and small life sciences and technology companies, often in multinational transactions. Types of work include venture capital and private equity investments, mergers and acquisitions, spin-offs, general corporate counseling, strategic alliances, executive compensation, licenses, collaborations, intellectual property matters, litigation, and other types of assistance.

Show More


  • Merger between two UK and US flu vaccine companies, and then a venture capital financing, on behalf of venture capital (VC) and private equity (PE) funds in Sweden, France, United Kingdom and Switzerland
  • Merger between a large Japanese pharma and our client, a US biotechnology company, for several hundred million dollars. Our client developed therapeutics for central nervous system conditions, such as attention deficit hyperactivity disorder (ADHD), and during its eight years of development and growth, we assisted with a reverse merger, two score VC closings with investors from three countries, and all aspects of its operations and growth

Show More


  • The Legal 500 Untied States, 2019
  • Practical Law Company, Recommended for M&A and Corporate Transactions
  • Law & Politics, Super Lawyer
  • Boston Magazine, Securities & Venture Finance


  • Massachusetts Biotechnology Council, member
  • Chambers of Commerce of France, Australia, Germany, Sweden, UK, member


Boston University School of Law, JD, 1977
Yale University, BA, 1970